
Clarisa Blattner: PAMA Reporting 2026—5 Strategic Priorities Clinical Laboratories Can’t Afford to Miss
Validating applicable laboratory status is an important first step in reporting

Validating applicable laboratory status is an important first step in reporting

Cuts to reimbursement rates under PAMA have been pushed back again by Congress, this time to January 2027

However, attorney Danielle Sloane urges labs to be proactive about potential PAMA reporting requirements on Jan. 31 if the bill doesn’t pass quickly

Better clinical laboratory test data reporting would allow ‘Medicare rates to be more appropriately set,’ says Susan Van Meter

The 2025 CLFS update—what has changed, what has stayed the same, and what that means for diagnostic test reimbursement in 2025